Aspyra Inc

Healthcare US APYI

0.0002USD
-(-%)

Last update at 2025-06-11T13:30:00Z

Day Range

0.00020.0002
LowHigh

52 Week Range

0.00020.0002
LowHigh

Fundamentals

  • Previous Close 0.0002
  • Market Cap0.02M
  • Volume0
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-3.65893M
  • Revenue TTM7.75M
  • Revenue Per Share TTM58.48
  • Gross Profit TTM 3.33M
  • Diluted EPS TTM-0.07

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2008-12-31 2007-12-31 2006-12-31 2005-12-31 2004-12-31
Type yearly yearly yearly yearly yearly
Date 2008-12-31 2007-12-31 2006-12-31 2005-12-31 2004-12-31
Income before tax -5.18130M -4.21489M -3.56563M -1.69490M -0.26413M
Minority interest 0.00000M 0.00000M 0.00000M 0.00000M -
Net income -5.18990M -4.21701M -3.57044M -2.50191M -0.26413M
Selling general administrative 6.22M 6.72M 7.25M 3.89M 3.87M
Selling and marketing expenses - - - - -
Gross profit 3.92M 4.87M 5.88M 3.51M 1.24M
Reconciled depreciation - - - - -
Ebit -3.82712M -4.19747M -3.34391M -1.68343M -0.26670M
Ebitda -2.26992M -2.60663M -1.95925M -1.10256M -0.08795M
Depreciation and amortization 1.56M 1.59M 1.38M 0.58M 0.18M
Non operating income net other 0.00000M 0.00000M 0.00000M 0.00000M -
Operating income 4.70M 4.20M 3.34M 1.68M 0.27M
Other operating expenses 12.65M 14.47M 16.03M 8.89M 2.66M
Interest expense 0.78M 0.17M 0.32M 0.04M 0.00202M
Tax provision - - - - -
Interest income - - - - -
Net interest income - - - - -
Extraordinary items 0.00000M 0.00000M 0.00000M 0.00000M -
Non recurring 0.02M 0.14M 0.02M 0.00000M -
Other items 0.00000M 0.00000M 0.00000M 0.00000M -
Income tax expense 0.00860M 0.00212M 0.00481M 0.81M -0.53339M
Total revenue 8.53M 10.27M 12.69M 7.21M 2.39M
Total operating expenses 8.04M 9.07M 9.23M 5.19M 1.51M
Cost of revenue 4.61M 5.40M 6.81M 3.70M 1.15M
Total other income expense net -0.57643M -8.41236M -6.90954M -3.37833M -0.53082M
Discontinued operations 0.00000M 0.00000M 0.00000M 0.00000M -
Net income from continuing ops -5.18990M -4.21701M -3.57044M -2.50191M -
Net income applicable to common shares -5.18990M -5.00603M -3.57044M -2.50191M 0.16M
Preferred stock and other adjustments 0.00000M 0.00000M 0.00000M 0.00000M -
Breakdown 2008-12-31 2007-12-31 2006-12-31 2005-12-31 2004-12-31
Type yearly yearly yearly yearly yearly
Date 2008-12-31 2007-12-31 2006-12-31 2005-12-31 2004-12-31
Total assets 15.16M 16.77M 19.30M 18.63M 6.59M
Intangible assets 5.92M 6.60M 6.94M 12.40M -
Earning assets - - - - -
Other current assets 0.78M 0.13M 0.09M 0.59M 0.80M
Total liab 8.37M 6.26M 6.50M 6.44M 2.68M
Total stockholder equity 6.79M 10.51M 12.80M 12.18M 3.91M
Deferred long term liab 0.00000M 0.00000M 0.00000M 0.00000M -
Other current liab 1.62M 1.62M 1.25M 1.23M 0.55M
Common stock 22.76M 22.76M 21.04M 16.97M 6.20M
Capital stock - - - - -
Retained earnings -18.55651M -13.36661M -8.36058M -4.79014M -2.28823M
Other liab 0.00000M 0.00000M 0.00000M 0.00000M -
Good will 6.69M 7.27M 7.27M 7.70M -
Other assets 0.21M 0.16M 0.18M 0.16M 1.95M
Cash -0.34829M 0.80M 1.01M 1.33M 1.66M
Cash and equivalents - - - - -
Total current liabilities 5.71M 5.91M 6.00M 6.22M 2.68M
Current deferred revenue 2.44M 2.16M 2.29M 2.78M 1.46M
Net debt 3.95M 0.90M 1.06M -0.11348M -1.35506M
Short term debt 0.95M 1.35M 1.57M 1.00M 0.30M
Short long term debt 0.74M 1.03M 1.42M 1.00M -
Short long term debt total 3.60M 1.70M 2.07M 1.22M 0.30M
Other stockholder equity 25.35M 23.94M 21.20M -0.00269M -
Property plant equipment 0.50M 0.84M 1.17M 0.51M 0.18M
Total current assets 1.84M 1.90M 3.74M 3.67M 4.27M
Long term investments 0.00000M 0.00000M 0.00000M 0.00000M -
Net tangible assets -5.82368M -3.35488M -1.40589M -2.10017M -
Short term investments 0.00000M 0.00000M 0.03M 0.00000M -
Net receivables 0.81M 0.92M 1.33M 1.55M 1.74M
Long term debt 2.46M 0.09M 0.02M 0.22M -
Inventory 0.03M 0.05M 0.11M 0.21M 0.09M
Accounts payable 0.71M 0.78M 0.89M 1.22M 0.38M
Total permanent equity 0.00000M 0.00000M 0.00000M 0.00000M -
Noncontrolling interest in consolidated entity 0.00000M 0.00000M 0.00000M 0.00000M -
Temporary equity redeemable noncontrolling interests 0.00000M 0.00000M 0.00000M 0.00000M -
Accumulated other comprehensive income -0.00036M -0.05993M -0.04473M -0.00269M -
Additional paid in capital 0.00000M 0.00000M 0.00000M 0.00000M -
Common stock total equity 0.00000M 0.00000M 0.00000M 0.00000M -
Preferred stock total equity 0.00000M 0.00000M 0.00000M 0.00000M -
Retained earnings total equity 0.00000M 0.00000M 0.00000M 0.00000M -
Treasury stock 0.00000M 0.00000M 0.00000M 0.00000M -
Accumulated amortization 0.00000M 0.00000M 0.00000M 0.00000M -
Non currrent assets other 0.21M 0.16M 0.18M 2.04M 1.72M
Deferred long term asset charges 0.00000M 0.00000M 0.00000M 0.00000M -
Non current assets total 13.32M 14.87M 15.55M 14.95M 2.32M
Capital lease obligations 0.00000M 0.00000M 0.00000M 0.00000M -
Long term debt total 0.00000M 0.00000M 0.00000M 0.00000M -
Breakdown 2008-12-31 2007-12-31 2006-12-31 2005-12-31 2004-12-31
Type yearly yearly yearly yearly yearly
Date 2008-12-31 2007-12-31 2006-12-31 2005-12-31 2004-12-31
Investments 0.00000M 0.00000M 0.00000M 0.00000M -
Change to liabilities 0.21M -0.23273M -0.82200M 0.47M 0.10M
Total cashflows from investing activities -0.55365M -0.92135M -1.21665M -2.66147M -
Net borrowings 2.31M -0.27622M 0.10M -0.03599M -
Total cash from financing activities 2.14M 2.34M 3.17M 2.98M 0.30M
Change to operating activities 0.10M 0.49M 0.27M -0.50611M -
Net income -5.18990M -4.21701M -3.57044M -2.50191M -0.26413M
Change in cash -0.02376M -0.21124M -0.31512M -0.32531M 0.08M
Begin period cash flow 0.80M 1.01M 1.33M 1.66M 1.57M
End period cash flow 0.78M 0.80M 1.01M 1.33M 1.66M
Total cash from operating activities -1.68602M -1.61803M -2.23110M -0.63813M 0.16M
Issuance of capital stock - - - - -
Depreciation 1.56M 1.59M 1.38M 0.58M 0.18M
Other cashflows from investing activities -0.01557M -0.20517M -0.03198M -0.68774M -0.17524M
Dividends paid 0.00000M 0.00000M 0.00000M 0.00000M -
Change to inventory 0.07M 0.11M 0.13M -0.07800M 0.04M
Change to account receivables 0.19M 0.35M 0.20M 0.56M 0.27M
Sale purchase of stock 0.00000M 0.43M -0.00023M 0.03M -
Other cashflows from financing activities -0.55365M 0.90M -1.46612M -2.66147M -0.37885M
Change to netincome 1.48M 0.29M 0.18M 0.84M -
Capital expenditures 0.55M 0.92M 1.22M 0.33M 0.20M
Change receivables 0.00000M 0.00000M 0.00000M 0.00000M -
Cash flows other operating 0.00000M 0.00000M 0.00000M 0.00000M -
Exchange rate changes 0.00000M 0.00000M 0.00000M 0.00000M -
Cash and cash equivalents changes 0.00000M 0.00000M 0.00000M 0.00000M -
Change in working capital 0.47M 0.71M -0.22427M 0.44M 0.21M
Stock based compensation 0.44M - - - -
Other non cash items 0.02M 0.29M 0.18M 0.05M 0.04M
Free cash flow -2.23967M -2.53938M -3.44775M -0.96385M -0.04407M

Peer Comparison

Sector: Healthcare Industry: Health Information Services

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
APYI
Aspyra Inc
- -% 0.0002 - - 0.0032 0.006 0.0032 -0.0069
GEHC
GE HealthCare Technologies Inc.
-0.13 0.18% 73.27 22.91 20.12 2.01 5.52 2.39 13.30
VEEV
Veeva Systems Inc Class A
-7.89 2.73% 280.66 54.61 33.22 12.83 6.73 11.14 58.84
MTHRF
M3 Inc
- -% 13.65 29.72 25.00 0.05 4.38 0.04 0.12
MTHRY
M3 Inc
-0.15 2.12% 6.92 31.84 26.25 0.05 4.60 0.04 0.12

Reports Covered

Stock Research & News

Profile

Aspyra Inc. provides health care products and services for the laboratory and imaging marketplaces. It offers engineered workflow solutions that include software, interfaces, hardware, and professional services to various markets comprising specialty labs, reference labs, clinics, hospitals, imaging centers, and orthopedic practices. The company was formerly known as Creative Computer Applications Inc. and changed its name to Aspyra Inc. in November 2005. Aspyra Inc. was founded in 1978 and is headquartered in Jacksonville, Florida.

Aspyra Inc

7400 Baymeadows Way, Jacksonville, FL, United States, 32256

Key Executives

Name Title Year Born
Mr. Gary W. Bennett Pres NA
Mr. Dennis Prichard VP of Laboratory Information Solutions Devel. & Operations NA
Mr. Gary W. Bennett President NA
Mr. Danny Chin Vice President of Operations NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes. This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API. Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.